These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 11036042)

  • 1. RNA polymerase inhibitors with activity against rifampin-resistant mutants of Staphylococcus aureus.
    O'Neill A; Oliva B; Storey C; Hoyle A; Fishwick C; Chopra I
    Antimicrob Agents Chemother; 2000 Nov; 44(11):3163-6. PubMed ID: 11036042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of and development of resistance to corallopyronin A, an inhibitor of RNA polymerase.
    Mariner K; McPhillie M; Trowbridge R; Smith C; O'Neill AJ; Fishwick CW; Chopra I
    Antimicrob Agents Chemother; 2011 May; 55(5):2413-6. PubMed ID: 21321139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the activity of the RNA polymerase inhibitor myxopyronin B against Staphylococcus aureus.
    Moy TI; Daniel A; Hardy C; Jackson A; Rehrauer O; Hwang YS; Zou D; Nguyen K; Silverman JA; Li Q; Murphy C
    FEMS Microbiol Lett; 2011 Jun; 319(2):176-9. PubMed ID: 21477256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effect of rpoB mutations on antibacterial activities of rifampicin and KRM-1648 against Staphylococcus aureus.
    Wichelhaus T; Schäfer V; Brade V; Böddinghaus B
    J Antimicrob Chemother; 2001 Feb; 47(2):153-6. PubMed ID: 11157898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic analysis of Staphylococcus aureus RNA polymerase mutants.
    Morrow TO; Harmon SA
    J Bacteriol; 1979 Jan; 137(1):374-83. PubMed ID: 33150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rifampin-resistance-associated mutations in the rifampin-resistance-determining region of the
    Guo Y; Cao X; Yang J; Wu X; Liu Y; Wan B; Hu L; Wang H; Yu F
    J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33507146
    [No Abstract]   [Full Text] [Related]  

  • 7. Biological cost of rifampin resistance from the perspective of Staphylococcus aureus.
    Wichelhaus TA; Böddinghaus B; Besier S; Schäfer V; Brade V; Ludwig A
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3381-5. PubMed ID: 12384339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of mutations in the rpoB gene that confer rifampin resistance in Staphylococcus aureus.
    Aubry-Damon H; Soussy CJ; Courvalin P
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2590-4. PubMed ID: 9756760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency, spectrum, and nonzero fitness costs of resistance to myxopyronin in Staphylococcus aureus.
    Srivastava A; Degen D; Ebright YW; Ebright RH
    Antimicrob Agents Chemother; 2012 Dec; 56(12):6250-5. PubMed ID: 23006749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of resistance mechanisms and biological characteristics of rifampicin-resistant Staphylococcus aureus strains selected in vitro.
    Wang C; Fang R; Zhou B; Tian X; Zhang X; Zheng X; Zhang S; Dong G; Cao J; Zhou T
    BMC Microbiol; 2019 Sep; 19(1):220. PubMed ID: 31533633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro evaluation of CBR-2092, a novel rifamycin-quinolone hybrid antibiotic: studies of the mode of action in Staphylococcus aureus.
    Robertson GT; Bonventre EJ; Doyle TB; Du Q; Duncan L; Morris TW; Roche ED; Yan D; Lynch AS
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2313-23. PubMed ID: 18443108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of rpoB mutations conferring rifampin resistance on fitness of Mycobacterium tuberculosis.
    Mariam DH; Mengistu Y; Hoffner SE; Andersson DI
    Antimicrob Agents Chemother; 2004 Apr; 48(4):1289-94. PubMed ID: 15047531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rifampin resistance in Mycobacterium kansasii is associated with rpoB mutations.
    Klein JL; Brown TJ; French GL
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3056-8. PubMed ID: 11600355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. rpoB mutations in Streptococcus mitis clinical isolates resistant to rifampin.
    Achour W; Guenni O; Fines M; Leclercq R; Ben Hassen A
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2757-9. PubMed ID: 15215145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rifampin Resistance rpoB Alleles or Multicopy Thioredoxin/Thioredoxin Reductase Suppresses the Lethality of Disruption of the Global Stress Regulator spx in Staphylococcus aureus.
    Villanueva M; Jousselin A; Baek KT; Prados J; Andrey DO; Renzoni A; Ingmer H; Frees D; Kelley WL
    J Bacteriol; 2016 Oct; 198(19):2719-31. PubMed ID: 27432833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-resistance of Escherichia coli RNA polymerases conferring rifampin resistance to different antibiotics.
    Xu M; Zhou YN; Goldstein BP; Jin DJ
    J Bacteriol; 2005 Apr; 187(8):2783-92. PubMed ID: 15805525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of spontaneous, In vitro-selected, rifampin-resistant mutants of Mycobacterium tuberculosis strain H37Rv.
    Morlock GP; Plikaytis BB; Crawford JT
    Antimicrob Agents Chemother; 2000 Dec; 44(12):3298-301. PubMed ID: 11083630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative antimycobacterial activities of rifampin, rifapentine, and KRM-1648 against a collection of rifampin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations.
    Moghazeh SL; Pan X; Arain T; Stover CK; Musser JM; Kreiswirth BN
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2655-7. PubMed ID: 8913484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective inhibition of rifampicin-resistant Chlamydia trachomatis by the novel DNA-dependent RNA polymerase inhibitor corallopyronin A.
    Shima K; Ledig S; Loeper N; Schiefer A; Pfarr K; Hoerauf A; Graspeuntner S; Rupp J
    Int J Antimicrob Agents; 2018 Oct; 52(4):523-524. PubMed ID: 30092271
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of rpoB mutations in rifampin-resistant clinical Mycobacterium tuberculosis isolates from Kuwait and Dubai.
    Ahmad S; Mokaddas E; Fares E
    Diagn Microbiol Infect Dis; 2002 Nov; 44(3):245-52. PubMed ID: 12493171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.